Role of neurotransmitters in immune-mediated inflammatory disorders: a crosstalk between the nervous and immune systems
- 28 September 2022
- journal article
- review article
- Published by Springer Nature in Neurological Sciences
- Vol. 44 (1) , 99-113
Abstract
Immune-mediated inflammatory diseases (IMIDs) are a group of common heterogeneous disorders, characterized by an alteration of cellular homeostasis. Primarily, it has been shown that the release and diffusion of neurotransmitters from nervous tissue could result in signaling through lymphocyte cell-surface receptors and the modulation of immune function. This finding led to the idea that the neurotransmitters could serve as immunomodulators. It is now manifested that neurotransmitters can also be released from leukocytes and act as autocrine or paracrine modulators. Increasing data indicate that there is a crosstalk between inflammation and alterations in neurotransmission. The primary goal of this review is to demonstrate how these two pathways may converge at the level of the neuron and glia to involve in IMID. We review the role of neurotransmitters in IMID. The different effects that these compounds exert on a variety of immune cells are also reviewed. Current and future developments in understanding the cross-talk between the immune and nervous systems will undoubtedly identify new ways for treating immune-mediated diseases utilizing agonists or antagonists of neurotransmitter receptors.Keywords
This publication has 190 references indexed in Scilit:
- GABA is an effective immunomodulatory moleculeAmino Acids, 2011
- Opioid Drug Abuse and Modulation of Immune Function: Consequences in the Susceptibility to Opportunistic InfectionsJournal of Neuroimmune Pharmacology, 2011
- Cholinergic imbalance in the multiple sclerosis hippocampusActa Neuropathologica, 2011
- 5-HT and the immune systemCurrent Opinion in Pharmacology, 2011
- Serotonin Activates Dendritic Cell Function in the Context of Gut InflammationThe American Journal of Pathology, 2011
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disordersNature Reviews Neuroscience, 2010
- Glutamate joins the ranks of immunomodulatorsNature Medicine, 2010
- Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2receptorBritish Journal of Pharmacology, 2008
- Mechanisms of glutamate release from astrocytesNeurochemistry International, 2008
- Neuroendocrine interactions in the immune systemCellular Immunology, 2008